股票 › MNKD
曼恩凯德制药 MNKD
美股市值排名 #3070
$3.90 +$0.14 (+3.72%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $3.85 -1.28%
开盘$3.92
昨收$3.76
当日区间$3.80 – $4.09
成交量4.99M
市值$1.25B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例57.7%-2.58 个百分点，较上季度
持仓机构数304-1 ，较上季度
内部人近期交易29次买入 / 21次卖出净买入
空头持仓比例7.92% 占流通股回补天数 5.1 · 截至 15 Oct 2026
卖空成交量占比31.1%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$6.46M（9个净流入日，11个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有27.9%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从9.03%降至7.92%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Rubric Capital Management LP | Hedge Fund | 2026/Q3 | +14,379,587 | 5.6% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +6,000,000 | 1.9% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +4,561,628 | 2.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +3,532,225 | 10.0% |
| Braidwell LP | Hedge Fund | 2026/Q3 | +3,458,429 | 1.1% |
| AQR Capital Management | Hedge Fund | 2026/Q3 | +3,316,723 | 1.2% |
| J. Goldman & Co., L.P. | Hedge Fund | 2026/Q3 | +816,589 | 0.3% |
| Frazier Life Sciences Management, LP | VC/PE Fund | 2026/Q3 | +700,000 | 2.1% |
| 180 Wealth Advisors, LLC | Family Office/Trust | 2026/Q3 | +667,648 | 1.5% |
| TSP Capital Management Group, LLC | Mutual Fund | 2026/Q3 | +628,700 | 1.2% |
| FMR | Mutual Fund | 2026/Q3 | +620,201 | 1.3% |
| Wells Fargo & Company | Public Company | 2026/Q3 | +615,939 | 0.5% |
| Susquehanna International Group, LLP | Private Company | 2026/Q3 | +599,809 | 0.4% |
| Mason Street Advisors, LLC | Insurance Company | 2026/Q3 | +592,050 | 0.2% |
| Balyasny Asset Management L.P. | Hedge Fund | 2026/Q3 | +477,594 | 0.2% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 24 Sep 2026 | Steven Binder | Independent Director | Automatic Disposition | -39,051 | $3.29 | 546,758 |
| 9 Sep 2026 | Steven Binder | Independent Director | Automatic Disposition | -33,558 | $3.81 | 585,809 |
| 6 Aug 2026 | Steven Binder | Independent Director | Automatic Disposition | -39,051 | $4.06 | 619,367 |
| 16 Jul 2026 | David Thomson | General Counsel | Automatic Disposition | -24,109 | $4.05 | 620,804 |
| 16 Jul 2026 | Steven Binder | Independent Director | Derivative Exercise and Sale | -76,880 | $4.09 | 658,418 |
| 14 Jul 2026 | David Thomson | General Counsel | Sale to Issuer | -4,636 | $4.09 | 620,804 |
| 14 Jul 2026 | David Thomson | General Counsel | Derivative Exercise and Sale | -93,790 | $4.09 | 620,804 |
| 14 Jul 2026 | Stuart Tross | Chief People & Workplace Officer | Derivative Exercise and Sale | -65,808 | $4.09 | 881,392 |
| 14 Jul 2026 | Stuart Tross | Chief People & Workplace Officer | Derivative Exercise and Retained | +27,982 | – | 881,392 |
| 14 Jul 2026 | Michael Castagna | Chief Executive Officer | Sale to Issuer | -12,940 | $4.09 | 2,433,779 |
| 14 Jul 2026 | Michael Castagna | Chief Executive Officer | Derivative Exercise and Sale | -350,260 | $4.09 | 2,433,779 |
| 14 Jul 2026 | Steven Binder | Independent Director | Derivative Exercise and Retained | +16,910 | – | 658,418 |
| 14 Jul 2026 | Christopher Prentiss | Chief Financial Officer | Sale to Issuer | -22,247 | $4.09 | 95,851 |
| 14 Jul 2026 | Dominic Marasco | President of Endocrine Business Unit | Sale to Issuer | -3,623 | $4.09 | 46,773 |
| 14 Jul 2026 | Sanjay Singh | Executive Vice President of Technical Operations | Derivative Exercise and Sale | -46,795 | $4.09 | 253,404 |
| 14 Jul 2026 | Sanjay Singh | Executive Vice President of Technical Operations | Derivative Exercise and Retained | +23,755 | – | 253,404 |
| 19 May 2026 | Ronald Consiglio | Independent Director | Other Acquisition | +10,000 | $2.95 | 132,342 |
| 19 May 2026 | Ronald Consiglio | Independent Director | Other Derivative Acquisition | +99,337 | – | 16,556 |
| 19 May 2026 | Christine Ann Mundkur | Independent Director | Other Derivative Acquisition | +82,781 | – | 82,781 |
| 19 May 2026 | Michael Friedman | Independent Director | Other Derivative Acquisition | +82,781 | – | 82,781 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 25,478,417 | 7.9% | 5.1 |
| 30 Sep 2026 | 26,157,578 | 8.1% | 4.4 |
| 15 Sep 2026 | 29,398,550 | 9.1% | 9.1 |
| 31 Aug 2026 | 26,554,857 | 8.3% | 8.5 |
| 14 Aug 2026 | 28,582,134 | 8.9% | 5.6 |
| 31 Jul 2026 | 27,895,392 | 9.0% | 6.2 |
暂无评论——快来第一个聊聊 MNKD。
登录后参与讨论。